Introduction
An important goal of gene therapy is to be able to deliver genes, so that they express in a pattern that recapitulates the expression of an endogenous cellular gene for proper function or for optimal effect of the delivered gene. Regulating transgene expression will also be an important component to reducing risks of adverse advents that may be associated with gene therapy, such as insertional transactivation of cellular genes. 1, 2 Diabetes mellitus, a major world health problem leading to early death and chronic ill health, is caused by the inability of the pancreatic b-cells in the islets of Langerhans to secrete adequate insulin to compensate for metabolic demand. Currently, loss of insulin production, whether by immune destruction or impaired compensatory growth of the b-cells, is irreversible. Islet cell transplantation is a potential therapy for diabetes mellitus, but routine transplantation has not become a standard treatment because of the limited supply of tissue and the problems associated with tissue rejection. Therefore, it is important to develop novel therapies for the treatment of diabetes mellitus. Effective tools to study gene modification of b-cells would enhance the development of novel therapies.
Lentivirus-based vectors are attractive gene delivery vehicles for b-cells because they can transduce non-dividing or slowly dividing cells and integrate into the host-cell genome for long-term gene expression. [3] [4] [5] Recent advances in lentiviral vector design have made it possible to self-inactivate (SIN) the native viral long-terminal repeat enhancer/promoter and to place an internal promoter, such as a tissue-specific promoter, in the expression cassette. 6, 7 Tissue-specific promoters are important for targeting gene expression to a particular cell type, but can be poor activators of transcription leading to inadequate levels of gene products making gene-expression studies in primary cells difficult. To overcome the limitations of low levels of expression from vectors using the insulingene promoter, we have developed lineage-specific lentiviral vectors that carry the human insulin promoter (HIP) in the two-step transcriptional amplification (TSTA) system to augment gene expression in pancreatic b-cells.
In this TSTA system, a weak promoter controls transcription of a synthetic transactivator composed of the yeast Gal4 DNA-binding domain fused to the Herpes simplex virus-1 (HSV-1) VP16 immediate early transactivator. 8, 9 This synthetic transactivator, in turn, binds to Gal4 DNA-responsive elements upstream of a minimal promoter. Wu and co-workers optimized the TSTA system using two tandem copies of HSV-1 VP16 in the transactivator element (Gal4VP 2 ) and five Gal4 DNA-binding sites in an adenoviral E4 minimal-promoter element (G5E4T). 10 When these elements were cloned into adenoviral 11 and lentiviral vectors, 12 the TSTA system successfully increased the level of prostate cancer cell-specific expression from a prostate-specific antigen promoter, while maintaining the lineage specificity of expression. Transcriptional activation has also worked successfully using neuron and astrocyte-specific promoters. 13, 14 In this study, we have compared gene expressions from lentiviral vectors containing the phosphoglycerate kinase (PGK) or the HIP using optimized components of the TSTA system. We have found that we can achieve between one-half and one-log amplification of the gene expression using the TSTA system. Importantly, we were able to amplify gene expression using the HIP, while preserving b-cell lineage specificity. Additionally, in primary islets, gene expression from lentiviral vectors carrying the HIP was coincident with insulin expression. The vector carrying the TSTA elements was able to amplify gene-expression two logs over the standard HIP vector.
Results

Viral titers and Southern blot analysis
We generated a series of SIN lentiviral vectors containing either the constitutive PGK promoter, which has a weak enhancer, or the HIP in the absence or presence of sequences from the TSTA system ( Figure 1a) . To compare gene expression from the TSTA elements in cis or trans configurations, the PGK promoter driving the transactivator sequences and the minimal promoter driving the enhanced green fluorescent protein (eGFP) reporter gene were cloned into either the same (cis) or separate (trans) lentiviral vectors. To compare gene expression from a vector containing the TSTA sequences with a vector containing the woodchuck posttranscriptional regulatory element (WPRE), which has been reported to enhance gene expression, 15 HIP lentiviral vectors containing the WPRE sequences were also generated.
Unconcentrated vector titers, as measured by vector copy number, could be obtained in the range of 10 3 -10 6 TU ml -1 ( Figure 1b) . The PGK and HIP vectors , transducing units per milliliter.
Amplifiable b-cell-specific lentiviral vectors KL Shaw et al that contained the TSTA elements in cis configuration had a two-log-and one-log-lower titer, respectively, compared with their standard counterpart vectors that did not contain the TSTA elements. This result indicated that the extra TSTA sequences lowered titers, especially in the context of the PGK promoter. Interestingly, when we directly compared the effective titer, as measured by eGFP expression, of the vectors that express eGFP with their DNA titer (Table 1) , the titers were similar. This result indicated that, at least of these vectors tested, they do not undergo silencing of eGFP expression. To determine whether these vectors could be packaged and delivered intact, we transduced HT29 cells and analyzed genomic DNA by Southern blot analysis. Except for the E4 min -eGFP vector, we detected integrated proviruses of the appropriate lengths ( Figure 2 ). In addition to the expected 1.8 kilo-base pair (kb) band for the E4 min -eGFP vector, a second band that was smaller than 1.6 kb was present, indicating that sequences from the E4 min -eGFP vector were being deleted. Interestingly, these same sequences in the context of the cis vectors (for example, PGK-A, HIP-LA) were not being deleted, as bands smaller than full length were not detected ( Figure 2, lanes 3 and 7) .
Previously, Zhang et al. 10 determined that two VP16 activation domains in the transactivator element and five Gal4 DNA-binding sites in the minimal-promoter element were optimal in the TSTA system for augmenting gene activity. To determine whether these tandem repeats were rearranging and/or deleting internally, we designed polymerase chain reaction (PCR) primers to amplify the 345-base pair (bp) fragment in Gal4VP 2 , containing the two copies of VP16, and the 170-bp fragment in G 5 E4T, containing the five copies of the Gal4 DNA-binding sites, and amplified these sequences from genomic DNA extracted from transduced cells. Only bands of the appropriate sizes were detected (Supplementary Figure 1 ), suggesting that these tandem repeats were being carried intact. Overall, lentiviral vectors could be generated that carried the TSTA system elements.
Comparison of gene expression between cis-and trans-amplified vectors
To investigate the effects of the TSTA elements in cis or trans configuration, we constructed lentiviral vectors that contained the PGK-promoter/Gal4VP 2 cassette and the (Figure 3a , middle panel). We surmised that this population comprised of cells that were transduced with both vectors, and the intensity of gene expression was the result of the TSTA elements interacting in trans. In other experiments, we sorted the eGFP hi cells produced from a PGK-G and E4 min -eGFP co-transduction and confirmed by Southern blot analysis of genomic DNA that these cells contained both vectors (data not shown). To increase the number of eGFP hi cells, we transduced with both the PGK-G and the E4 min -eGFP vectors at MOI 10 each, which resulted in an increase in the number of eGFP lo cells as well as an increase in the number of eGFP hi cells (Figure 3a , right panel). However, even at high MOI, only 3% of the cells were eGFP hi , indicating that co-transduction HT-29 cells with two vectors were inefficient.
To compare gene expression from the cis vector (containing both the transactivator gene and the response element in a single construct) with the trans vectors, we transduced HT-29 cells with PGK-A at MOI 1 and 10. Increasing the MOI led to an appreciable increase in the total number of eGFP-positive cells (Figure 3b , compare middle and right panels). Additionally, with the cis vector, a single MOI 10 was sufficient to obtain the same number of eGFP hi cells as a total MOI 20 (MOI 10 PGK-G vector+MOI 10 E4 min-vector) needed with the trans vectors, indicating that transactivation of gene expression is more efficient in the cis vector. Interestingly, at the high MOI, a small population of eGFP lo cells, which was Abbreviation: TU, transducing units. Amplifiable b-cell-specific lentiviral vectors KL Shaw et al similar to the eGFP lo population from the E4 min -eGFP vector, could be seen. This population may represent the basal gene expression from the minimal promoter, although it is unclear why transactivation is not occurring in these cells. Of note, gene expression (that is, MFI) was approximately four-fold greater from the trans vectors than from the cis vector ( Figure 3a and b, compare right panels), although we do not know why this is the case. In a separate experiment, we sorted the eGFP hi cells and confirmed that each sorted population contained one vector copy. When we compared the MFI, there was again an approximately four-fold greater MFI from the trans vectors (data not shown). Therefore, the discrepancy in MFI is probably not due to greater efficiency of transduction by the trans vectors. It is possible that the placement of the TSTA elements in the cis vector is not optimal and higher gene expression may be achieved by rearranging the TSTA elements (see Discussion). However, because of the inefficiency of using the trans vectors and because the E4 min-eGFP vector itself is not carried intact (Figure 2 ), experiments were continued using only vectors in the cis configuration.
Comparison of gene expression between standard and amplified vectors
Next, we studied further the level of gene-expression enhancement from the amplified vectors compared with the standard vectors. We transduced cells at low MOI to yield single-low vector copy numbers per cell and compared gene expression using MFI when the pool of eGFP-expressing cells was between 1 and 10%. Gene expression from the amplified PGK vector (PGK-A) compared with the standard PGK vector was increased approximately 2.5-to 4-fold in HT-29 and Hep G2 cells, respectively, 10-fold in HEK293 and NIT-1 cells, and 18-fold in Beta-TC-6 cells ( Figure 4 ). Thus, for the vector with the non-specific PGK promoter, the TSTA elements increased expression levels in all cell types assayed.
The HIP vectors express in a lineage-specific manner
To determine whether the HIP vectors express in a lineage-specific pattern, we compared gene expression in insulin-producing b-cells (Beta-TC-6, NIT-1, and Min6), non-insulin-producing cells (HEK293, Hep G2, and To show that the lack of gene expression was not due to the lack of transduction, we extracted genomic DNA from transduced HEK293, HT-29, and NIT-1 cells and determined vector copy number by quantitative PCR. We found that, although HIP vectors did not express in HEK293 and HT-29, the cells carried similar vector copy numbers as cells that were transduced with the constitutively expressing PGK vector ( Table 2 ). The HIP vectors were functional because they were capable of expressing and transferring similar vector copy numbers to NIT-1 cells. Therefore, gene expression from the HIP vectors was limited to b-type cells even though different cell types could be transduced, and the TSTA elements could enhance gene expression from the HIP without compromising the cell-type specificity of this promoter.
Amplified gene expression is associated with increased levels of mRNA
We next studied the eGFP mRNA species produced from the different vectors. Although one eGFP mRNA is expected from each of the standard vectors with or without the WPRE, two eGFP mRNA species are possible from the amplified vectors: one smaller mRNA that is initiated from the TATA box in the adenoviral E4 minimal promoter and a second, larger mRNA that is initiated from the upstream PGK or HIP internal promoter (Figure 6a ). We extracted total RNA from PGK or PGK-A-transduced Beta-TC-6 cells that were cell sorted for their eGFP expression. We detected the appropriate 1.16 kb eGFP mRNA from PGK-transduced cells ( Figure 6b, lane 2) . The predominant eGFP mRNA detected from PGK-A-transduced cells was the shorter, 1.18 kb, amplified message produced from the E4 minimal promoter. We detected a larger, but weaker, eGFP mRNA of B2.27 kb, which corresponded to the size expected for the mRNA initiating from the PGK promoter ( Figure 6b, lane 3) .
To directly correlate the levels of eGFP mRNA to MFI produced from the different vectors, we transduced Beta-TC-6 cells with the HIP, HIP-LA, or HIP-W vector at the same MOI. Each of the transduced pools had a similar number of eGFP-positive cells and vector copy number, which verified that the cells were transduced similarly (Figure 6c ). Similar to earlier results ( Figure 5 ), the HIP-LA vector-amplified gene expression of approximately five-fold over the HIP vector, whereas the HIP-W vector showed increased gene expression of approximately 2.5-fold over the HIP vector. Total RNA was extracted from these low-copy number-transduced pools and analyzed by northern blot for eGFP mRNA. Notably, the intensity of the eGFP bands correlated with MFI. The HIP vector, which had the lowest MFI, had the lowest intensity band; the HIP-W vector, which had an intermediate MFI, had an intermediate intensity band; and the HIP-LA vector, which had the highest MFI, had the highest intensity band (Figure 6d, upper panel) . This result was quantified by measuring the intensities of the bands by densitometry (Figure 6d, lower panel) . Similar ) . Therefore, the intensity of eGFP gene expression is directly proportional to the amount of eGFP mRNA produced; although the presence of the WPRE increased eGFP mRNA production, the presence of the TSTA elements greatly increased eGFP mRNA production through amplification.
Optimal gene expression in primary human islets is achieved from the amplified HIP vector To determine whether eGFP-expression correlated with insulin expression, an aliquot of each sample of the transduced cells was subjected to immunohistochemistry analysis. As expected, the PGK vector drove eGFP expression in insulin-positive and insulin-negative cells, whereas gene expression from the lineage-specific HIP vectors was restricted to insulin-positive cells (Figure 8 ). In islets that were transduced with the HIP-LA vector, we detected two intensities of eGFP expression, which correlated with the flow cytometry data. Very bright eGFP-expression correlated with insulin expression (Figure 8 , fourth column, long arrows), whereas very dim eGFP expression did not (Figure 8 , fourth column, short arrow). Additionally, bright eGFP expression from the HIP-LA vector was so intense that it required a 10-fold shorter exposure time, compared with HIP and HIP-W vectors to visualize the green cells (data not shown).
We have shown that lentiviral vectors carrying the HIP express in a lineage-specific manner, and we have produced a transcriptionally amplified HIP vector that can specifically amplify gene expression in primary human b-cells. This development will facilitate geneexpression studies in primary cells that were hindered earlier by undetectable or weak signals from the insulin promoter.
Discussion
Developing vectors with better regulated expression is important to advancing the field of gene therapy. One method to regulate gene expression is to use tissuespecific gene regulatory elements, such as enhancers and promoters. The intact, 1.4 kb HIP contains all of the functional elements necessary for tissue-specific expression and glucose responsiveness. 17 Although full promoter activity can be defined and preserved, tissue-specific promoters tend to be poor activators of transcription, especially outside the context of their native, chromosomal environment, making gene-expression studies difficult. We have developed lentiviral vectors that amplify gene expression from the HIP using a TSTA method. TSTA elements have been used to boost gene expression from weak cancer-specific promoters [18] [19] [20] and have been useful for non-invasive imaging studies in developmental Figure 8 Immunohistochemistry analysis for eGFP and insulin in transduced human islets. Aliquots of transduced islets from Figure 7 were cytospun and simultaneously stained for eGFP (green) and insulin (red). Cell nuclei were stained with DAPI (blue). Islets transduced with HIP-LA (fourth column) had eGFP bright cells that were also insulin positive (compare second and third rows, long arrows) as well as eGFP dim cells that were insulin negative (short arrow). Amplifiable b-cell-specific lentiviral vectors KL Shaw et al biology 21 and cancer therapy. 11, 12, 19, 22 Here, we have shown that gene amplification from the HIP is superior in gene expression in primary human islets.
We developed cis-and trans-amplifying vectors to determine the optimal functional context for the TSTA elements. Interestingly, the sequences that comprised the minimal E4 promoter and eGFP gene were not carried intact in the context of the trans vector (E4 min -eGFP), but were carried intact in the context of the cis vectors (PGK-A and HIP-LA). For this reason, studies were continued using only the cis vectors. It is possible that cryptic splice donor and/or splice acceptor sites were created during construction of the E4 min -eGFP vector and not of the cis vectors.
In HT-29 cells, gene expression from the trans vectors (PGK-G and E4 min -eGFP) was approximately three-fold greater than from the cis vector (PGK-A; Figure 3 ). It is possible that, in the context of a lentiviral vector, the placement of the TSTA elements in the cis vector was not optimal for amplifying gene expression compared with the trans vectors. Although we do not know the reason for this difference in expression levels, it is possible that expression from our cis vector is affected by 'transcriptional interference,' which occurs when one transcription unit represses an adjacent unit when the two lay head-totail in tandem in a single construct. [23] [24] [25] Transcriptional interference is believed to be caused by inaccessibility or competitive binding of the transcriptional machinery to the two proximal promoters. Whether this is the case or not, we believe that the effect of transcriptional interference is low in our system because the second transcriptional unit is comprised of a minimal promoter, which would minimize binding of non-specific or unnecessary transcription factors.
We observed a basal level of expression from the vector carrying only the adenoviral E4 minimal promoter. This 'leaky' expression could be due to the activity of nearby enhancer elements in the chromosome where the vector integrated or from residual activity of the SIN long-terminal repeat of the lentiviral vector itself 26 on the E4 minimal promoter. It may be possible to decrease the basal-promoter activity by using an alternative minimal promoter, such as that from the HSV-1 thymidine kinase gene, the long terminal repeat of the mouse mammary tumor virus, 18 or the fish E1b basal promoter, as others have done in conjunction with the Gal4/VP16 transactivator. 21 The addition of insulator elements to block out exogenous enhancer activity would also be beneficial for decreasing basal level expression.
The WPRE has been reported to increase gene expression from onco-and lentiviral vectors by augmenting RNA processing. 27, 28 In agreement with a study conducted by Zufferey et al., 15 we also observed an increase in gene-expression levels when the WPRE was present, which corresponded to an increase in RNA levels. When compared directly, the presence of the TSTA elements increased gene-expression and RNA levels several-fold more than the WPRE. Although the WPRE improves RNA processing to increase gene expression, we believe that the TSTA elements produce large amounts of mRNA for translation, through transcriptional amplification, resulting in increased gene expression.
In primary human islets, we observed the same stepwise increase in gene expression from the standard to the WPRE containing, to the amplified vector, as we observed in the insulinoma cell lines. We are perplexed that two different populations of eGFP-expressing cells are present in the islets that were transduced with the HIP-LA vector. That the very bright eGFP cells correlated with insulin staining, while the very dim eGFP cells did not, indicated that gene expression was amplified in a cell-specific manner. It is possible that the E4 minimal promoter was weakly active in the non-b-cells of the islet cultures. However, this non-specific expression was dimmer than the expression from the standard HIP vector. We estimate that gene expression from the HIP vector in primary b-cells is 10 to 20 times lower than gene expression from the HIP-LA vector based on the flow cytometry and immunofluorescence studies. Therefore, we do not think that the very low, non-specific expression from the HIP-LA vector precludes its usefulness in gene-expression studies.
The islet experiments were repeated with a different batch of primary human islets, and similar results were obtained. Although it is expected that gene expression would persist long term, we did not keep the cultures for more than 7 days after transduction, as the cells would have de-differentiated in long-term culture. At 7 days, the viability of the cultures remained high (480%) with no decrease in eGFP expression (data not shown). Future experiments will be to determine whether labeled b-cells can be isolated by sorting and cultured viably to obtain a pure population of gene-modified cells.
In summary, we have developed a lentiviral vector that enhances gene expression from the HIP while preserving lineage specificity in b-cells. In primary human islets, compared with the non-amplified lineage-specific vectors, gene expression was superior. Geneamplified lineage-specific vectors will be useful tools for studying gene modification of primary cells.
Materials and methods
Cell lines
The human embryonic kidney cell line HEK293, human colorectal adenocarcinma cell line HT-29, human hepatocellular carcinoma cell line Hep G2, rat pancreatic tumor cell line ARIP, human pancreatic epithelial carcinoma cell line Panc-1, and murine pancreatic insulinoma cell lines Beta-TC-6 and NIT-1 were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). The murine insulinoma cell line Min6 was provided by Gay Crooks at Childrens Hospital Los Angeles. The HEK293 and HT-29 cell lines were maintained in Dulbecco's modified Eagle medium (Mediatech, Inc., Herndon, VA, USA) containing 10% fetal bovine serum (FBS; Omega Scientific, Inc., Tarzana, CA, USA), 2 mM L-glutamine, 100 units ml -1 penicillin, and 100 mg ml -1 streptomycin (Gemini Bio-products, West Sacramento, CA, USA). The Hep G2 cell line was maintained in Eagle's minimum essential medium (ATCC) containing 10% FBS, L-glutamine, and penicillin-streptomycin. The ARIP cell line was maintained in F-12K medium (ATCC) containing 10% FBS, L-glutamine, and penicillin-streptomycin. The Beta-TC-6, NIT-1, Min6, and Panc-1 cell lines were maintained in Dulbecco's modified Eagle medium modified to contain 1.5 g l -1 sodium bicarbonate (ATCC), 15% FBS, L-glutamine, and
Amplifiable b-cell-specific lentiviral vectors KL Shaw et al penicillin-streptomycin. All cell lines were maintained in a 37-1C incubator with 5% CO 2 .
Lentiviral vectors
All HIV-1-based lentiviral vectors used in this study were based on the pCCL SIN vector backbone developed by Luigi Naldini 7 or the SMPU SIN vector backbone developed by Paula Cannon (Childrens Hospital Los Angeles, Los Angeles, CA, USA). 29 These vectors contain the central polypurine tract and rev response element sequences. In our hands, gene expression was similar between pCCL and SMPU vectors that carried the same gene regulatory elements (data not shown). Two internal promoters were used in these studies: the 570 bp murine PGK promoter and the 1. Vector supernatant production and titers Lentiviral vector supernatants were produced by triple transfection of HEK293T cells. To produce concentrated vector supernatant, 5 Â 10 7 cells were seeded onto a 500-cm square plate, 1 day before transfection. Cells were transfected by DNA/calcium phosphate co-precipitation with 20 mg pMD.G (VSV-G), 100 mg pRD8.9 packaging plasmid, 30 and 100 mg of vector plasmid. At 48 to 72 h posttransfection, vector supernatants were harvested, clarified by passing through a 0.45-mm membrane, and crudely concentrated using Centricon plus 70 ultrafiltration filters (Millipore, Bredford, MA, USA). Crude supernatants were ultracentrifuged at 500 Â g for 2 h, and concentrated supernatants were stored at À70 1C until used. Vector supernatants could be concentrated to between 10 7 and 10 9 TU ml -1 , as determined by vector copy analysis by quantitative PCR (data not shown).
Comparison of titers was determined from unconcentrated vector supernatants, which were produced in small scale by calcium phosphate triple transfection of 1.8 Â 10 6 HEK293T cells seeded in 35 mm dishes with 3.6 mg pRD8.9, 3.6 mg vector plasmid, and 1 mg pMD.G. After exposure of sub-confluent HT-29 cells to 10-fold serial dilutions of unconcentrated vector supernatant for 6 days, genomic DNA was extracted and the vector copy number was determined by quantitative PCR. The number of transducing units per milliliter was calculated by multiplying the vector copy number, which was extrapolated from a standard curve of known vector copy number, the number of cells at the time of supernatant addition, and the supernatant dilution.
For the experiment to compare copy number titer to expression titer, small scale supernatants were produced as described above. Sub-confluent HT-29 cells were exposed to 10-fold serial dilutions of unconcentrated PGK or PGK-A vector supernatants for 6 days. Subconfluent Beta-TC-6 cells were exposed to 10-fold serial dilutions of unconcentrated HIP, HIP-LA, or HIP-W vector supernatants for 6 days. After exposure, the cells were collected and one-half was aliquoted for genomic DNA extraction and vector copy number analysis, as described above, and the second half was aliquoted for eGFP-expression analysis by flow cytometry. The expression titer was calculated by multiplying the number of eGFP-positive cells, the number of cells at the time of supernatant addition, and the supernatant dilution.
Transduction of cell lines
To facilitate evaluation of expression in cells with a single copy of vector, aliquots of cells were transduced with a series of half-log serial dilutions of each supernatant. Cells were transduced by the addition of diluted supernatant in the presence of 8 mg ml -1 polybrene (Sigma, St Louis, MO, USA) to aliquots of 10 5 cells in a total volume of 1 ml. The proportion of cells expressing eGFP was determined by flow cytometry 5-7 days later with detailed expression analysis performed on cells transduced by the supernatant dilution that yielded o10% positive cells.
Human islet culture and transduction
Human pancreatic islets were received from the Islet Cell Resource Centers Basic Science Islet Distribution Program and the National Disease Research Interchange. Immediately after receipt, islets were dissociated into smaller cell clusters using Dispase (BD Biosciences, San José, CA, USA) and were plated onto 96-well plates coated with HTB-9 matrix 16 at approximately 200 islets per well. After an overnight recovery period, cells were transduced with the selected vectors using a final vector concentration of 3 Â 10 6 TU ml -1 in a total volume of 50 ml. Cells were maintained in RPMI-1640 containing 5.5 mM glucose 5 days before analysis.
Southern blot analysis
For each vector, 1 Â 10 5 HT-29 cells in a 35-mm tissue culture dish were transduced and grown to confluency. The transduced cells were expanded until confluent in a 100-mm tissue culture dish, and genomic DNA were extracted using a standard phenol/chloroform procedure. Ten micrograms of genomic DNA was digested overnight with the appropriate restriction enzymes (single or double digestions with Afl II, Bgl II, EcoR V, Kpn I, Nar I; New England Biolabs, Ipswich, MA, USA; Supplementary Figure 3) to release an intact proviral fragment that spanned 5 0 of the internal promoter to 3 0 of the eGFP gene. Digested DNA was separated on an agarose gel by electrophoresis, blotted onto Hybond-XL nylon membrane (Amersham, Buckinghamshire, UK), hybridized with 32 P-labeled DNA probe spanning 741 bp of the eGFP gene, and exposed to Kodak X-Omat film.
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Northern blot analysis
For bulk eGFP mRNA analysis in Beta-TC-6 cells, 1 Â 10 5 cells were transduced with the appropriate vector and expanded to 2 Â 10 6 cells. Pools of eGFP-positive cells were isolated by fluorescence-activated cell sorting (FACS) using an FACSVantage cytometer (Becton Dickinson, San Diego, CA, USA) using CellQuest software, and sorted cells were grown to confluency in a 100-mm tissue culture dish. For quantitative comparison of eGFP mRNA from HIP vectors, Beta-TC-6 cells were transduced with a series of half-log serial dilutions of each supernatant to obtain transduced pools with similar, low vector copy number. Transduced pools having similar numbers of eGFP-positive cells were expanded to confluency in 100 mm tissue culture dishes. Total cellular RNA were isolated using an RNeasy Midi Kit (Qiagen Inc., Valencia, CA, USA) according to manufacturer's protocol. Five micrograms of total cellular RNA were separated on an agarose gel by electrophoresis, blotted onto Hybond-XL nylon membrane, hybridized with 32 P-labeled DNA probe spanning 741 bp of the eGFP gene, and exposed to Kodak X-Omat film. To validate equal RNA gel loading for each sample, blotted nylon membranes were stripped of radioactively labeled eGFP probes using 0.1 M NaOH, and re-probed with 32 P-labeled human b-actin cDNA probe (Clontech, Mountain View, CA, USA) for HT-29 RNA or 32 P-labeled mouse b-actin DECAprobe (Ambion, Austin, TX, USA) for Beta-TC-6 RNA.
Flow cytometric analysis and cell sorting
For flow cytometry analysis of eGFP expression in cell lines, cells were harvested using trypsin, resuspended in cell culture medium, washed, and resuspended in phosphate buffered saline (PBS). For flow cytometry analysis of eGFP expression in primary human islets, islets were washed and resuspended in PBS. The samples were analyzed on an FACScan using CellQuest software (Becton Dickinson). Transduced cells for eGFP mRNA analysis were sorted using an FACSVantage cytometer (Becton Dickinson) based on eGFP expression, collected in the appropriate cell culture medium containing 30% FBS, and cultured as indicated above.
Vector copy number analysis in transduced cell lines
The vector copy number was determined by RT-PCR analysis. Genomic DNA were extracted using the DNeasy Tissue Kit (Qiagen Inc.) according to the manufacturer's protocols. Lentiviral vector sequences were amplified using a 200-nM concentration each of a sense primer (5 0 -ACCTGAAAGCGAAAGGGAAAC-3 0 ) and an anti-sense primer (5 0 -CGCACCCATCTCTCTCCT TCT-3 0 ), which spans 146 bp in the vector genomic packaging signal (c). Each PCR amplification reaction was performed with 150-300 ng of genomic DNA in Taqman Universal PCR Master Mix (Applied Biosystems Inc., Foster City, CA, USA). Amplified vector sequences were detected with 50 nM probe (5 0 -6FAMAGCTCTCTC GACGCAGGACTCGGCTAMRA-3 0 ), which is homologous to vector sequences internal to the primers. Samples and standards were run in duplicate. Each PCR run included a standard curve of genomic DNA with known lentiviral vector copy numbers of 2, 0.2, 0.02, and 0.002 vector copies per cell. PCR amplification was performed in an Applied Biosystems GeneAmp 7700 sequence detection system instrument with denaturation at 95 1C for 10 min and followed by 40 cycles of amplification, which included denaturation at 95 1C for 15 s and annealing and extension at 60 1C for 60 s. Analysis was performed using the Sequence Detection software (version 1.9.1).
Densitometry analysis
Radiographic bands produced on an X-ray film were converted to a photographic image at 600 dots per inch resolution using a flatbed scanner. The densities of the bands of interest were calculated using Kodak 1D 3.6 software (Rochester, NY, USA) and corrected for background by subtracting out a 'mock' reading and normalized for loading by dividing by densities of b-actin bands in those lanes.
Immunohistochemistry
Cytospin slides were prepared from an aliquot of sample that was used for flow cytometry analysis. Cells were fixed with 4% paraformaldehyde solution for 15 min, followed by three, 5 min washes with PBS containing 0.05% Tween-20 (PBS-T; Sigma-Aldrich, St Louis, MO, USA). The sample was 'blocked' with PBS-T containing 10% (v/v) normal donkey serum (Jackson ImmunoResearch, West Grove, PA, USA) and 0.1% Triton X-100 (Sigma-Aldrich). The slides were incubated overnight at 4 1C in the presence of the following primary antibodies: 1:200 dilution of polyclonal guinea-pig anti-insulin antibody (Dako, Carpinteria, CA, USA) and 1:1000 dilution of polyclonal rabbit anti-green fluorescent protein antibody (Invitrogen, Carlsbad, CA, USA). After the overnight incubation, slides were washed three times with PBS-T and incubated for 45 min with secondary antibody (1:250 dilution of Cy3-conjugated donkey anti-guinea-pig (Jackson ImmunoResearch) and 1:500 dilution of Alexa-488-conjugated donkey anti-rabbit antibody (Invitrogen). The slides were washed several times with PBS-T and mounted using Vectashield mounting medium with DAPI (Vector Laboratories, Burlingame, CA, USA). Fluorescent images were obtained with a Leica DM RXA upright fluorescent microscope using EasyFISH software (Applied Spectral Imaging, Vista, CA, USA).
